Evar

Endovascular Aneurysm Repair (EVAR) Market Report 2021: Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, July 5, 2021
Hospitals, Pharmaceutical, Health, Medical specialties, Angiology, Cardiovascular system, Vascular surgery, Vascular diseases, Interventional radiology, Endovascular aneurysm repair, Evar, Aneurysm, Neurosurgery, Open aortic surgery, Aortic aneurysm

The "Endovascular Aneurysm Repair (EVAR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Endovascular Aneurysm Repair (EVAR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global endovascular aneurysm repair market exhibited moderate growth during 2015-2020.
  • Looking forward, the global endovascular aneurysm repair market to grow at a CAGR of around 5% during the forecast period (2021-2026).
  • Due to the prevalence of aneurysms, along with the growing geriatric population, endovascular treatment is increasingly being adopted by healthcare providers.

Endologix LLC Announces Launch of ALTO® Abdominal Stent Graft System in Canada and Argentina

Retrieved on: 
Tuesday, May 11, 2021
Health, Surgery, Cardiology, Medical devices, Interventional radiology, Medical specialties, Vascular surgery, Medicine, Endovascular aneurysm repair, Clinical medicine, Evar, Stent, XC2, Abdominal Aortic Aneurysm (AAA), the ALTO Abdominal Stent Graft System, Endologix’s Product Portfolio, Endologix, ABDOMINAL AORTIC ANEURYSM (AAA), THE ALTO ABDOMINAL STENT GRAFT SYSTEM, ENDOLOGIX’S PRODUCT PORTFOLIO, ENDOLOGIX

b"Endologix LLC , a leader in the treatment of vascular disease, today announced the first implant of its ALTO\xc2\xae Abdominal Stent Graft in Canada following recent approval from Health Canada.

Key Points: 
  • b"Endologix LLC , a leader in the treatment of vascular disease, today announced the first implant of its ALTO\xc2\xae Abdominal Stent Graft in Canada following recent approval from Health Canada.
  • View the full release here: https://www.businesswire.com/news/home/20210511005366/en/\nFeaturing a unique, patented, sealing technology, the ALTO Abdominal Stent Graft System is the latest generation in polymer-based therapies for AAA patients.
  • ALTO utilizes a low-profile delivery system and, unlike standard EVAR devices, features an exclusive conformable sealing ring that molds in-situ to the patient\xe2\x80\x99s specific aortic neck anatomy.
  • The company\xe2\x80\x99s current commercial EVAR products include the AFX\xc2\xae2 device and the ALTO\xc2\xae Abdominal Stent Graft System.

Study of patients undergoing abdominal aortic aneurysm repair suggests screening guidelines may be inadequate

Retrieved on: 
Tuesday, January 5, 2021
Medical specialties, Angiology, Medicine, Vascular surgery, Aortic aneurysm, Abdominal aortic aneurysm, Endovascular aneurysm repair, Screening, Evar, Abdominal ultrasonography, Aneurysm, Thoracic aortic aneurysm

Rosemont, Ill., Jan. 05, 2021 (GLOBE NEWSWIRE) -- A retrospective study analyzing approximately 55,000 patients undergoing abdominal aortic aneurysm (AAA) repair suggests current AAA screening guidelines may be inadequate in detecting a significant number of new cases.

Key Points: 
  • Rosemont, Ill., Jan. 05, 2021 (GLOBE NEWSWIRE) -- A retrospective study analyzing approximately 55,000 patients undergoing abdominal aortic aneurysm (AAA) repair suggests current AAA screening guidelines may be inadequate in detecting a significant number of new cases.
  • The study patients were enrolled in the Vascular Quality Initiative between years 2003 and 2019.
  • Screening guidelines derived from the 2005 U.S. Preventive Services Task Force (USPTF) recommendations involve a one-time abdominal ultrasound examination only for men aged 65-75 with a history of smoking.
  • Our study additionally describes the clinical characteristics and outcomes in patients undergoing EVAR and open surgery who did not meet the currently accepted screening guidelines.

Centerline Biomedical Kicks Off First Clinical Study of Intra-Operative Positioning System Technology

Retrieved on: 
Tuesday, December 15, 2020
Medical specialties, Medicine, Clinical medicine, Cardiac surgery, Open aortic surgery, Evar, Endovascular aneurysm repair, Computer-assisted surgery, Clinical trial, Cleveland Clinic

CLEVELAND, Dec. 15, 2020 /PRNewswire/ -- Centerline Biomedical, Inc. (Centerline) announced Tuesday the completion of the first surgical case in its MOTION clinical study of its innovative Intra-Operative Positioning System (IOPS) surgical navigation platform.

Key Points: 
  • CLEVELAND, Dec. 15, 2020 /PRNewswire/ -- Centerline Biomedical, Inc. (Centerline) announced Tuesday the completion of the first surgical case in its MOTION clinical study of its innovative Intra-Operative Positioning System (IOPS) surgical navigation platform.
  • The FDA-cleared technology is already being deployed in a controlled launch at Cleveland Clinic and other leading institutions in the United States.
  • The MOTION study will be used to support the company's submission for market clearance in Europe and other international markets.
  • The primary objective of the MOTION study is to formally clinically evaluate the effectiveness and safety of the technology in providing accurate navigation during endovascular aortic repair (EVAR) procedures.

Endologix Receives CE Mark for ALTO Abdominal Stent Graft System

Retrieved on: 
Wednesday, August 5, 2020
Biotechnology, Medical devices, Other Health, Health, Cardiology, Medical specialties, Interventional radiology, Angiology, Cardiovascular system, Vascular surgery, Endovascular aneurysm repair, Vascular diseases, Evar, Aneurysm, Stent

Transforming the treatment of aortic disorders, Endologix Inc. (OTC: ELGXQ) (Endologix or the Company), today announced that it has received a CE Mark for the ALTO Abdominal Stent Graft System (ALTO).

Key Points: 
  • Transforming the treatment of aortic disorders, Endologix Inc. (OTC: ELGXQ) (Endologix or the Company), today announced that it has received a CE Mark for the ALTO Abdominal Stent Graft System (ALTO).
  • We are very excited to receive a CE Mark for the ALTO system, that has been achieved through a strong partnership and collaboration with our European notified body, NSAI commented Matt Thompson, Chief Medical Officer of Endologix.
  • In addition, with ALTO, we anticipate observing improved short-term outcomes relative to the Ovation iX Abdominal Stent Graft System (Ovation iX) as a result of the design and manufacturing changes incorporated into ALTO.
  • Lastly, CE Mark of the ALTO system is yet another critical milestone for Endologix as we seek to introduce a portfolio of devices to address the current unmet needs of endovascular aneurysm repair (EVAR).

Endologix Announces First Commercial Implant of ALTO Abdominal Stent Graft System & Official Start of U.S. Commercial Release

Retrieved on: 
Thursday, July 30, 2020
Science, Other Science, Biotechnology, Research, General Health, Health, Medical devices, Other Health, Medical specialties, Angiology, Interventional radiology, Cardiovascular system, Vascular surgery, Endovascular aneurysm repair, Vascular diseases, Evar, Aneurysm, Stent, Open aortic surgery, Abdominal aortic aneurysm

ALTO represents a differentiation from traditional endovascular aneurysm repair (EVAR) and, with its introduction, a significant landmark for Endologix.

Key Points: 
  • ALTO represents a differentiation from traditional endovascular aneurysm repair (EVAR) and, with its introduction, a significant landmark for Endologix.
  • With its unique anatomically adaptive sealing technology, ALTO offers patients improved acute outcomes and the ability to preserve long-term durability.
  • ALTO offers a workhorse endograft with broad indications to treat the widest range of patients.
  • The first commercial implant marks the official start of the U.S. release of the ALTO Abdominal Stent Graft System.

Endologix Issues Correction Notice for Ovation iX Abdominal Stent Graft System

Retrieved on: 
Monday, June 15, 2020
Science, Cardiology, Other Science, Research, Surgery, Health, Medical devices, Other Health, Medical specialties, Angiology, Medicine, Vascular surgery, Endovascular aneurysm repair, Interventional radiology, Evar, Vascular diseases, Polymer, Aneurysm, Ovation

Endologix is committed to replacing Ovation iX with the recently FDA-approved ALTO graft by the end of October 2020.

Key Points: 
  • Endologix is committed to replacing Ovation iX with the recently FDA-approved ALTO graft by the end of October 2020.
  • Ovation iX is differentiated from traditional devices for endovascular aneurysm repair (EVAR) through the use of liquid polymer.
  • In the transition to ALTO, physicians may be considering when to select Ovation iX for their patients given the root cause of polymer leaks.
  • To clarify the decision-making process, Endologix has updated the labelling of the Ovation iX platform with the following warning: Polymer leaks are a unique potential risk of the Ovation iX device platform that have been reported post-market.

COVID-19 Impact and Recovery Analysis- Aortic Stent Grafts Market 2020-2024 | Rising Preference for EVAR to Boost Growth | Technavio

Retrieved on: 
Thursday, June 11, 2020
Medical Supplies, Medical devices, Health, Surgery, General Health, Cardiology, Medical specialties, Medicine, Interventional radiology, Angiology, Vascular surgery, Vascular diseases, Endovascular aneurysm repair, Stent, Evar, Aneurysm

View the full release here: https://www.businesswire.com/news/home/20200610005672/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200610005672/en/
    Technavio has announced its latest market research report titled Global Aortic Stent Grafts Market 2020-2024 (Photo: Business Wire).
  • Market estimates include pre- and post-COVID-19 impact on the Aortic Stent Grafts Market Download free sample report
    The market is concentrated, and the degree of concentration will accelerate during the forecast period.
  • Rising preference for Endovascular Aneurysm Repair (EVAR) procedures has been instrumental in driving the growth of the market.
  • https://www.technavio.com/report/report/aortic-stent-grafts-market-indus...
    Aortic Stent Grafts Market 2020-2024: Segmentation
    Aortic Stent Grafts Market is segmented as below:

Global Aortic Stent Grafts Market 2020-2024 | Evolving Opportunities with Cook group Inc. and CryoLife Inc. | Technavio

Retrieved on: 
Thursday, January 9, 2020
Health, Surgery, Medical Supplies, Medical devices, Medical specialties, Medicine, Angiology, Vascular surgery, Interventional radiology, Vascular diseases, Endovascular aneurysm repair, Aortic aneurysm, Evar, Aneurysm, Stent

Technavio has been monitoring the global aortic stent grafts market since 2014 and the market is poised to grow by USD 690.09 million during 2020-2024 at a CAGR of over 5% during the forecast period.

Key Points: 
  • Technavio has been monitoring the global aortic stent grafts market since 2014 and the market is poised to grow by USD 690.09 million during 2020-2024 at a CAGR of over 5% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20200109005361/en/
    Technavio has announced its latest market research report titled global aortic stent grafts market 2020-2024.
  • (Graphic: Business Wire)
    Read the 153-page research report with TOC on "Aortic Stent Grafts Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Application (AAA and TAA), and Segment Forecasts, 2020-2024".
  • The rising preference for MI endovascular aneurysm repair (EVAR) to treat aortic aneurysms and technological advances are anticipated to boost the growth of the market.

Global Endovascular Aneurysm Repair (EVAR) Market by Indication, Product, Gender, Age, End-user & Region - Forecast to 2024

Retrieved on: 
Tuesday, November 26, 2019
Medical specialties, Angiology, Cardiovascular system, Vascular surgery, Vascular diseases, Interventional radiology, Endovascular aneurysm repair, Evar, Aneurysm

DUBLIN, Nov. 26, 2019 /PRNewswire/ -- The "Endovascular Aneurysm Repair (EVAR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 26, 2019 /PRNewswire/ -- The "Endovascular Aneurysm Repair (EVAR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
  • The global endovascular aneurysm repair market is expected to grow at a CAGR of 8% during 2019-2024.
  • How has the global endovascular aneurysm repair market performed so far and how will it perform in the coming years?
  • What is the structure of the global endovascular aneurysm repair industry and who are the key players?